オリゴヌクレオチドAPIの世界市場2020年-2030年

◆英語タイトル:Oligonucleotide Api Market - Global Industry Analysis and Opportunity Assessment, 2020-2030
◆商品コード:FMI20OT047
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2020年7月17日
◆ページ数:181
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、オリゴヌクレオチドAPIの市場を広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、市場ボリューム分析・予測、市場価値分析・予測、API種類別(アンチセンスオリゴヌクレオチドAPI、短鎖干渉RNA(siRNA)API、ホスホロジアミデートモルホリノオリゴヌクレオチド(PMO)API、MiRNA API、アプタマーAPI)分析、マーケティングステータス別分析、エンドユーザー別分析、地域別分析、市場構造分析、競争分析、仮定、調査手法と今後の方向性を明らかに致します。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・市場状況
・市場ボリューム分析・予測
・市場価値分析・予測
・オリゴヌクレオチドAPIの世界市場規模:API種類別(アンチセンスオリゴヌクレオチドAPI、短鎖干渉RNA(siRNA)API、ホスホロジアミデートモルホリノオリゴヌクレオチド(PMO)API、MiRNA API、アプタマーAPI)
・オリゴヌクレオチドAPIの世界市場規模:マーケティングステータス別
・オリゴヌクレオチドAPIの世界市場規模:エンドユーザー別
・オリゴヌクレオチドAPIの世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the Oligonucleotide API market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.

Oligonucleotide API Market: Segmentation

The global Oligonucleotide API market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

[API Type]
Antisense Oligonucleotides API
Short Interfering RNA (siRNA) API
Phosphorodiamidate Morpholino Oligonucleotides (PMO) API
MiRNA API
Aptamers API
CpG Oligonucleotides API
Others (ON Conjugates (NP), ShRNA, etc.)

[Marketing Status]
Marketed
Clinical Trials (Clinical Phases)

[End User]
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Development & Manufacturing Organizations (CDMOs)

[Region]
North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA

Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the Oligonucleotide API market, which includes a snapshot of key findings and statistics. It also includes market size and revenue distribution of market segments of the market.

Chapter 02 – Market Overview
Readers can find the detailed segmentation of the Oligonucleotide API market in this chapter, which will help them understand the basics of the market.

Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the Oligonucleotide API market over the forecast period. It also helps reader to understand both – supply side and demand side trends of the market.

Chapter 04 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis along with current COVID-19 impact that are expected to influence growth of the Oligonucleotide API market over the forecast period. Moreover, in-depth information about the market dynamics and their impact on the market have been provided in the successive section.

Chapter 05 – Market Context
This section includes premium insights such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. it helps readers understand the key factors associated with the Oligonucleotide API market.

Chapter 06 – 6. Oligonucleotide API Market Volume Analysis (in Kg/Tons) 2015-2019 and Forecast 2020-2030
This section highlights the global market pricing analysis by equipment type. It helps readers to understand the pricing variation of whole slide scanner in various geographies.

Chapter 07 – Global Oligonucleotide API Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030
This section explains the global market value analysis and forecast for the Oligonucleotide API during the forecast period. It includes a detailed analysis of the historical Oligonucleotide API market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 08 – Global Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030, by API Type
Based on API Type, the market is segmented into antisense oligonucleotides API, Short Interfering RNA (siRNA) API, phosphorodiamidate morpholino oligonucleotides (PMO) API, MiRNA API, aptamers API, CpG Oligonucleotides API and Others (ON Conjugates (NP), ShRNA, etc.). In this chapter, readers can find information about the key trends and developments in Oligonucleotide API and market attractiveness analysis based on API Type.

Chapter 09 – Global Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030, by Marketing Status
This chapter provides details about the Oligonucleotide API based on Marketing Status, and has been classified into marketed, clinical trials (Clinical Phases) based. In this chapter, readers can understand the market attractiveness analysis based on Marketing Status.

Chapter 10 – Global Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030, by End User
This chapter provides details about the Oligonucleotide API market based on end user, and comprises contract manufacturing organizations (CMOS), pharmaceutical companies, and biopharmaceutical companies. The readers can understand the market attractiveness based on end user.

Chapter 11 – Global Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030, by Region
This chapter explains how the market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 12 – North America Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter includes a detailed analysis of growth of North America’s Oligonucleotide API market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.

Chapter 13 – Latin America Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter provides the growth scenario of the market in Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 14 –Europe Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter provides the growth scenario of the market in Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 15 – East Asia Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter highlights the growth of the market in East Asia by focusing on China, Japan & South Korea. This section also help readers understand the key factors that are responsible for the growth of the Oligonucleotide API market in East Asia.

Chapter 16 – South Asia Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter provides the growth scenario of the Oligonucleotide API market in India, Thailand, Indonesia, Malaysia and rest of South Asia.

Chapter 17 – Oceania Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter highlights the growth of the Oligonucleotide API market in Oceania. It also helps readers understand the key factors that are responsible for the growth of the Oligonucleotide API market in Australia and New Zealand.

Chapter 18 – MEA Oligonucleotide API Analysis 2015-2019 and Forecast 2020-2030
This chapter provides information about how the Oligonucleotide API market will grow in GCC Countries, South Africa, Turkey and the Rest of MEA during the forecast period.

Chapter 19 – Key and Emerging Countries Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030
This section delves deep into Oligonucleotide API market for key and emerging countries. Readers can understand the market value and volume by API type, marketing status, and end user for key countries.

Chapter 20 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key players operating in Oligonucleotide API market.

Chapter 21 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Oligonucleotide API market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Jazz Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics., Alnylam Pharmaceuticals, Inc. among others.

Chapter 22 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the Oligonucleotide API report.

Chapter 23 – Research Methodology
This chapter helps readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Oligonucleotide API market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Assessment

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Research and Developmental Activities

4.2.2. Product Formulation Advancement

4.2.3. Key Players Historical Growth

4.2.4. Market Consolidation Activities

4.2.5. Growing Investment by Key Players in Product Development

4.3. Current COVID19 Statistics and Probable Future Impact

4.3.1. Current GDP Projection and Probable Impact

4.3.2. Current Economic Projection as compared to 2008 financial analysis

4.3.3. COVID19 and Impact Analysis

4.3.4. 2020 Market Scenario

4.3.5. Recovery Scenario – Short term, Midterm and Long Term Impact

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunities

5. Market Context

5.1. Product USPs/ Features

5.2. Product Adoption / Usage Analysis

5.3. Regulatory Scenario

5.4. Opportunity Analysis For The Products Under Late Stage Clinical Trial

5.5. Revenue Breakdown by Region by Approved Market Products

5.6. Supply-Chain Analysis

5.7. Value Chain Analysis

6. Oligonucleotide API Market Volume (in Kg/Tons) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Volume (Kg/Tons) Analysis, 2015-2019

6.2. Current and Future Market Volume (Kg/Tons) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

7. Global Oligonucleotide API Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Opportunity Analysis, 2020-2030

8. Global Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030, By API Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) & Volume (Kg/Tons) Analysis By API Type, 2015-2019

8.3. Current and Future Market Size (US$ Mn) & Volume (Kg/Tons) Analysis and Forecast By API Type, 2020-2030

8.3.1. Antisense Oligonucleotides API

8.3.2. Short Interfering RNA (siRNA) API

8.3.3. Phosphorodiamidate Morpholino Oligonucleotides (PMO) API

8.3.4. MiRNA API

8.3.5. Aptamers API

8.3.6. CpG Oligonucleotides API

8.3.7. Others (ON Conjugates (NP), ShRNA, etc.)

8.4. Market Attractiveness Analysis By API Type

9. Global Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Marketing Status, 2015-2019

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Marketing Status, 2020-2030

9.3.1. Marketed

9.3.2. Clinical Trials (Clinical Phase)

9.4. Market Attractiveness Analysis By Marketing Status

10. Global Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030, by End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

10.3.1. Contract Manufacturing Organizations (CMOs)

10.3.2. Pharmaceutical & Biopharmaceutical Companies

10.3.3. Contract Development & Manufacturing Organizations (CDMOs)

10.4. Market Attractiveness Analysis By End User

11. Global Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030, by Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa

11.4. Market Attractiveness Analysis By Region

12. North America Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By API Type

12.3.3. By Marketing Status

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By API Type

13.3.3. By Marketing Status

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By API Type

14.3.3. By Marketing Status

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By API Type

15.3.3. By Marketing Status

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By API Type

16.3.3. By Marketing Status

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By API Type

17.3.3. By Marketing Status

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By API Type

18.3.3. By Marketing Status

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Oligonucleotide API Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Oligonucleotide API Market Analysis

19.2.1. By API Type

19.2.2. By Marketing Status

19.2.3. By End User

19.3. Canada Oligonucleotide API Market Analysis

19.3.1. By API Type

19.3.2. By Marketing Status

19.3.3. By End User

19.4. Mexico Oligonucleotide API Market Analysis

19.4.1. By API Type

19.4.2. By Marketing Status

19.4.3. By End User

19.5. Brazil Oligonucleotide API Market Analysis

19.5.1. By API Type

19.5.2. By Marketing Status

19.5.3. By End User

19.6. U.K. Oligonucleotide API Market Analysis

19.6.1. By API Type

19.6.2. By Marketing Status

19.6.3. By End User

19.7. Germany Oligonucleotide API Market Analysis

19.7.1. By API Type

19.7.2. By Marketing Status

19.7.3. By End User

19.8. France Oligonucleotide API Market Analysis

19.8.1. By API Type

19.8.2. By Marketing Status

19.8.3. By End User

19.9. Italy Oligonucleotide API Market Analysis

19.9.1. By API Type

19.9.2. By Marketing Status

19.9.3. By End User

19.10. Spain Oligonucleotide API Market Analysis

19.10.1. By API Type

19.10.2. By Marketing Status

19.10.3. By End User

19.11. BENELUX Oligonucleotide API Market Analysis

19.11.1. By API Type

19.11.2. By Marketing Status

19.11.3. By End User

19.12. Russia Oligonucleotide API Market Analysis

19.12.1. By API Type

19.12.2. By Marketing Status

19.12.3. By End User

19.13. China Oligonucleotide API Market Analysis

19.13.1. By API Type

19.13.2. By Marketing Status

19.13.3. By End User

19.14. Japan Oligonucleotide API Market Analysis

19.14.1. By API Type

19.14.2. By Marketing Status

19.14.3. By End User

19.15. South Korea Oligonucleotide API Market Analysis

19.15.1. By API Type

19.15.2. By Marketing Status

19.15.3. By End User

19.16. India Oligonucleotide API Market Analysis

19.16.1. By API Type

19.16.2. By Marketing Status

19.16.3. By End User

19.17. ASEAN Oligonucleotide API Market Analysis

19.17.1. By API Type

19.17.2. By Marketing Status

19.17.3. By End User

19.18. Australia Oligonucleotide API Market Analysis

19.18.1. By API Type

19.18.2. By Marketing Status

19.18.3. By End User

19.19. New Zealand Oligonucleotide API Market Analysis

19.19.1. By API Type

19.19.2. By Marketing Status

19.19.3. By End User

19.20. GCC Countries Oligonucleotide API Market Analysis

19.20.1. By API Type

19.20.2. By Marketing Status

19.20.3. By End User

19.21. Turkey Oligonucleotide API Market Analysis

19.21.1. By API Type

19.21.2. By Marketing Status

19.21.3. By End User

19.22. South Africa Oligonucleotide API Market Analysis

19.22.1. By API Type

19.22.2. By Marketing Status

19.22.3. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1. Regional Footprint by Players

20.3.2. Product Foot print by Players

20.3.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive (Tentative List)

21.3.1. Agilent Technologies, Inc.

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Strategy Overview

21.3.1.5.1. Marketing Strategy

21.3.1.5.2. Product Strategy

21.3.1.5.3. Channel Strategy

21.3.2. Bachem Holding AG

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Strategy Overview

21.3.2.5.1. Marketing Strategy

21.3.2.5.2. Product Strategy

21.3.2.5.3. Channel Strategy

21.3.3. CordenPharma International

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Strategy Overview

21.3.3.5.1. Marketing Strategy

21.3.3.5.2. Product Strategy

21.3.3.5.3. Channel Strategy

21.3.4. Integrated DNA Technologies, Inc. (Danaher Corporation)

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Strategy Overview

21.3.4.5.1. Marketing Strategy

21.3.4.5.2. Product Strategy

21.3.4.5.3. Channel Strategy

21.3.5. Eurofins Scientific

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Strategy Overview

21.3.5.5.1. Marketing Strategy

21.3.5.5.2. Product Strategy

21.3.5.5.3. Channel Strategy

21.3.6. GE Healthcare

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Strategy Overview

21.3.6.5.1. Marketing Strategy

21.3.6.5.2. Product Strategy

21.3.6.5.3. Channel Strategy

21.3.7. Merck KGaA

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Strategy Overview

21.3.7.5.1. Marketing Strategy

21.3.7.5.2. Product Strategy

21.3.7.5.3. Channel Strategy

21.3.8. Thermo Fisher Scientific

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Strategy Overview

21.3.8.5.1. Marketing Strategy

21.3.8.5.2. Product Strategy

21.3.8.5.3. Channel Strategy

21.3.9. RiBoBio Co.

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Strategy Overview

21.3.9.5.1. Marketing Strategy

21.3.9.5.2. Product Strategy

21.3.9.5.3. Channel Strategy

21.3.10. LGC Biosearch Technologies

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Strategy Overview

21.3.10.5.1. Marketing Strategy

21.3.10.5.2. Product Strategy

21.3.10.5.3. Channel Strategy

21.3.11. ST Pharm

21.3.11.1. Overview

21.3.11.2. Product Portfolio

21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Strategy Overview

21.3.11.5.1. Marketing Strategy

21.3.11.5.2. Product Strategy

21.3.11.5.3. Channel Strategy

21.3.12. Kaneka Eurogentec S.A.

21.3.12.1. Overview

21.3.12.2. Product Portfolio

21.3.12.3. Profitability by Market Segments (Product/Channel/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Strategy Overview

21.3.12.5.1. Marketing Strategy

21.3.12.5.2. Product Strategy

21.3.12.5.3. Channel Strategy

21.3.13. Ajinomoto Co., Inc.

21.3.13.1. Overview

21.3.13.2. Product Portfolio

21.3.13.3. Profitability by Market Segments (Product/Channel/Region)

21.3.13.4. Sales Footprint

21.3.13.5. Strategy Overview

21.3.13.5.1. Marketing Strategy

21.3.13.5.2. Product Strategy

21.3.13.5.3. Channel Strategy

21.3.14. Bio-synthesis Inc.

21.3.14.1. Overview

21.3.14.2. Product Portfolio

21.3.14.3. Profitability by Market Segments (Product/Channel/Region)

21.3.14.4. Sales Footprint

21.3.14.5. Strategy Overview

21.3.14.5.1. Marketing Strategy

21.3.14.5.2. Product Strategy

21.3.14.5.3. Channel Strategy

21.3.15. STA Pharmaceutical Co., Ltd.

21.3.15.1. Overview

21.3.15.2. Product Portfolio

21.3.15.3. Profitability by Market Segments (Product/Channel/Region)

21.3.15.4. Sales Footprint

21.3.15.5. Strategy Overview

21.3.15.5.1. Marketing Strategy

21.3.15.5.2. Product Strategy

21.3.15.5.3. Channel Strategy

21.3.16. BioSpring GmbH

21.3.16.1. Overview

21.3.16.2. Product Portfolio

21.3.16.3. Profitability by Market Segments (Product/Channel/Region)

21.3.16.4. Sales Footprint

21.3.16.5. Strategy Overview

21.3.16.5.1. Marketing Strategy

21.3.16.5.2. Product Strategy

21.3.16.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Table 01: Global Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 02: Global Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 03: Global Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 04: Global Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 05: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 06: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 07: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 08: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 09: Latin America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 10: Latin America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 11: Latin America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 12: Latin America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 13: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 14: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 15: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 16: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 17: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 18: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 19: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 20: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 21: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 22: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 23: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 24: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 25: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 27: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 28: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Table 29: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 30: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Table 31: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Marketing Status

Table 32: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 01: Global Oligonucleotide API Market Size (US$ Mn) Analysis, 2015–2019

Figure 02: Global Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2020–2030

Figure 03: Global Oligonucleotide API Market Absolute $ Opportunity Analysis, 2020–2030

Figure 04: Global Oligonucleotide API Market Analysis by API Type –2020 & 2030

Figure 05: Global Oligonucleotide API Market Y-o-Y Growth Projections by API Type, 2020 – 2030

Figure 06: Global Oligonucleotide API Market Attractiveness Analysis By API Type, 2020-2030,

Figure 07: Global Oligonucleotide API Market Analysis by Marketing Status –2020 & 2030

Figure 08: Global Oligonucleotide API Market Y-o-Y Growth Projections by Marketing Status, 2020 – 2030

Figure 09: Global Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Marketing Status

Figure 10: Global Oligonucleotide API Market Analysis by End User –2020 & 2030

Figure 11: Global Oligonucleotide API Market Y-o-Y Growth Projections by End User, 2020 – 2030

Figure 12: Global Oligonucleotide API Market Attractiveness Analysis 2020-2030, By End User

Figure 13: Global Oligonucleotide API Market Share Analysis (%) By Region, 2020 & 2030

Figure 14: Global Oligonucleotide API Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 15: Global Oligonucleotide API Market Attractiveness Analysis 2020-2030, By Region

Figure 16: North America Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 17: North America Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 18: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 19: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 20: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 21: North America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 22: Latin America Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 23: Latin America Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 24: Latin America Medical America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 25: Latin America Medical America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 26: Latin America Medical America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 27: Latin America Medical America Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 28: Europe Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 29: Europe Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 30: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 31: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 32: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 33: Europe Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 34: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 35: East Asia Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 36: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 37: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 38: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 39: East Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 40: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 41: South Asia Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 42: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 43: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 44: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 45: South Asia Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 46: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 47: Oceania Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 48: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 49: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 50: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 51: Oceania Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 52: MEA Oligonucleotide API Market Size (US$ Mn) Analysis, 2015-2019

Figure 53: MEA Oligonucleotide API Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030

Figure 54: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Figure 55: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by API Type

Figure 56: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, Marketing Status

Figure 57: MEA Oligonucleotide API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User

Figure 58: China Market Value Proportion Analysis, 2020

Figure 59: China Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 60: China. Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 61: China. Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 62: Global Vs. China Growth Comparison

Figure 63: India Market Value Proportion Analysis, 2020

Figure 64: India. Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 65: India. Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 66: India. Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 67: Global Vs. India Growth Comparison

Figure 68: Brazil Market Value Proportion Analysis, 2020

Figure 69: Brazil. Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 70: Brazil. Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 71: Brazil. Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 72: Global Vs. Brazil Growth Comparison

Figure 73: U.S Market Value Proportion Analysis, 2020

Figure 74: U.S. Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 75: U.S. Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 76: U.S. Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 77: Global Vs. U.S Growth Comparison

Figure 78: Canada Market Value Proportion Analysis, 2020

Figure 79: Canada Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 80: Canada Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 81: Canada Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 82: Global Vs. Canada Growth Comparison

Figure 83: Mexico Market Value Proportion Analysis, 2020

Figure 84: Mexico Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 85: Mexico Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 86: Mexico Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 87: Global Vs. Mexico Growth Comparison

Figure 88: Argentina Market Value Proportion Analysis, 2020

Figure 89: Argentina Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 90: Argentina Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 91: Argentina Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 92: Global Vs. Argentina Growth Comparison

Figure 93: U.K. Market Value Proportion Analysis, 2020

Figure 94: U.K. Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 95: U.K. Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 96: U.K. Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 97: Global Vs. U.K Growth Comparison

Figure 98: Germany Market Value Proportion Analysis, 2020

Figure 99: Germany Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 100: Germany Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 101: Germany Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 102: Global Vs. Germany Growth Comparison

Figure 103: France Market Value Proportion Analysis, 2020

Figure 104: France Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 105: France Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 106: France Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 107: Global Vs. France Growth Comparison

Figure 108: Italy Market Value Proportion Analysis, 2020

Figure 109: Italy Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 110: Italy Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 111: Italy Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 112: Global Vs. Italy Growth Comparison

Figure 113: Spain Market Value Proportion Analysis, 2020

Figure 114: Spain Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 115: Spain Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 116: Spain Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 117: Global Vs. Spain Growth Comparison

Figure 118: Russia Market Value Proportion Analysis, 2020

Figure 119: Russia Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 120: Russia Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 121: Russia Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 122: Global Vs. Russia Growth Comparison

Figure 123: Japan Market Value Proportion Analysis, 2020

Figure 124: Japan Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 125: Japan Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 126: Japan Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 127: Global Vs. Japan Growth Comparison

Figure 128: South Korea Market Value Proportion Analysis, 2020

Figure 129: South Korea Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 130: South Korea Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 131: South Korea Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 132: Global Vs. South Korea Growth Comparison

Figure 133: Indonesia Market Value Proportion Analysis, 2020

Figure 134: Indonesia Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 135: Indonesia Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 136: Indonesia Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 137: Global Vs. Indonesia Growth Comparison

Figure 138: Malaysia Market Value Proportion Analysis, 2020

Figure 139: Malaysia Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 140: Malaysia Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 141: Malaysia Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 142: Global Vs. Malaysia Growth Comparison

Figure 143: Thailand Market Value Proportion Analysis, 2020

Figure 144: Thailand Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 145: Thailand Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 146: Thailand Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 147: Global Vs. Thailand Growth Comparison

Figure 148: Australia Market Value Proportion Analysis, 2020

Figure 149: Australia Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 150: Australia Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 151: Australia Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 152: Global Vs. Australia Growth Comparison

Figure 153: New Zealand Market Value Proportion Analysis, 2020

Figure 154: New Zealand Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 155: New Zealand Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 156: New Zealand Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 157: Global Vs. New Zealand Growth Comparison

Figure 158: South Africa Market Value Proportion Analysis, 2020

Figure 159: South Africa Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 160: South Africa Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 161: South Africa Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 162: Global Vs. South Africa Growth Comparison

Figure 163: GCC Countries Market Value Proportion Analysis, 2020

Figure 164: GCC Countries Oligonucleotide API Market Share Analysis (%) By API Type, 2020 & 2030

Figure 165: GCC Countries Oligonucleotide API Market Share Analysis (%) By Marketing Status, 2020 & 2030

Figure 166: GCC Countries Oligonucleotide API Market Share Analysis (%) By End User, 2020 & 2030

Figure 167: Global Vs. GCC Countries Growth Comparison

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[オリゴヌクレオチドAPIの世界市場2020年-2030年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆